Buy Ipca Laboratories, target price Rs 1,774: Dharmesh Shah
The analyst suggested a stoploss at Rs 1625.

Ipca Laboratories Ltd., incorporated in 1949, has a market cap of Rs 21254.95 crore.
Investment Rationale
Price breakout from the last 10 weeks'triangular consolidation pattern and MACD in striong uptrend.
Quarterly Results

For the quarter ended March 31, 2020, the company reported consolidated sales of Rs 1073.76 crore, down -11.47 per cent from last quarter sales of Rs 1212.86 crore and up 22.07 per cent from last year's same quarter sales of Rs 879.61 crore. The company reported net profit after tax of Rs 85.38 crore in the latest quarter.
Promoter/FII Holdings
Promoters held 46.07 per cent stake in the company as of March 31, 2020, while FIIs held 12.64 per cent, DIIs 26.72 per cent and public and others 14.56 per cent.
Download ET Markets APP